Estadísticas de Cost-effectiveness analysis of sequential treatment strategies for moderate to severe Crohn’s disease in Spain: where should biosimilar ustekinumab be positioned?
Visitas totales
| views | |
|---|---|
| Cost-effectiveness analysis of sequential treatment strategies for moderate to severe Crohn’s disease in Spain: where should biosimilar ustekinumab be positioned? | 6 |
Visitas totales por mes
| views | |
|---|---|
| enero 2026 | 0 |
| febrero 2026 | 0 |
| marzo 2026 | 0 |
| abril 2026 | 0 |
| mayo 2026 | 0 |
| junio 2026 | 6 |
| julio 2026 | 0 |
Descargas
| views | |
|---|---|
| rodriguez_cost_2026.pdf | 6 |
Visitas por país
| views | |
|---|---|
| España | 5 |
| Israel | 1 |
Visitas por ciudad
| views | |
|---|---|
| Bilbao | 5 |
| Tel Aviv | 1 |